Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter), Diabetes (Type1 & 2) Population, & Forecast

July 2018 | | ID: E657F8792BFEN
Renub Research

Abstracts

Europe CGM Market is expected to surpass US$ 800 Million by the end of year 2024. Good healthcare infrastructure, rising healthcare expenditure and awareness of patients regarding CGM technology in Europe will further accelerate the market of Continuous Glucose Monitoring (CGM) device. Continuous Glucose Monitoring (CGM) device are comparatively new innovation in diabetes management. The conventional technique that permit users for one time check of glucose levels, but the CGM systems manage, monitor and inform the user if the glucose level nears current levels. The CGM system measures glucose from the tissues as compared to manual testing of blood by a finger-stick glucose meter assists in identifying glucose levels for a longer span of time.

Generally people who suffer from diabetes develop poor habits over the years which gradually seem hard to break. Using CGM systems that assist to control the desired glucose level by well awareness and understanding of food intake and blood glucose trends after eating specific foods.

Germany & France CGM Market will remain a dominant force in European Region

According to this market research report Germany & France is expected to be a dominant force in Europe Continuous Glucose Monitoring (CGM) market. The adoption of CGM device is comparatively faster in Sweden compared to other European region. As per many diabetes experts, CGM is the compatible device for effective diabetes management for people having severe complications (hypoglycemia or hyperglycemia) in day to day life.

European Countries Reimbursement Policies on CGM Device

This report provides complete assessment of CGM reimbursement for specific countries that includes: United Kingdom, Germany, France, Sweden, Switzerland and Netherlands. Many countries provide CGM reimbursement to pediatric, gestational diabetes and type 1 diabetes patients only. It is anticipated that continuous glucose monitoring systems will be widely accessible to all diabetes patients whether it type 1 or type 2.

Renub Research latest study “Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the Europe CGM Market. This report studies the Continuous Glucose Monitoring (CGM) market from 3 view points:

• CGM Market
• CGM Users
• CGM Reimbursements Policy

Countries Covered

1. Germany
2. France
3. Netherlands
4. Switzerland
5. Sweden
6. United Kingdom

Scope of the Report

• CGM Market & Forecast: We have defined CGM market of 6 countries. Market data from 2010 to 2017 and Forecast from 2018 to 2024
• CGM Users & Forecast: We have defined CGM number of Users of 6 countries. Market data from 2010 to 2017 and Forecast from 2018 to 2024
• Reimbursement Policy: Report provides Reimbursement Policy on CGM for 6 countries individually along with global CGM (Continuous Glucose Monitoring) reimbursement model
• Diabetes Population: Report covers 6 Countries Type 1 and Type 2 Diabetes Population Numbers and Forecast
• Growth Factors for CGM: This topic studies the factor which is helping the CGM industry to grow.
• Challenges for CGM: This industry shows the problems being faced by the CGM technology

Contents

1. EXECUTIVE SUMMARY

2. EUROPE – CGM USER (2010 – 2024)

3. EUROPE – CGM MARKET & FORECAST (2010 – 2024)

4. BY COMPONENTS – CGM MARKET (2010 – 2024)

4.1 Glucose Sensor Market & Forecast
4.2 CGM Transmitter Market & Forecast

5. MARKET SHARE – BY COUNTRIES

6. REIMBURSEMENT MODEL – EUROPE CGM (CONTINUOUS GLUCOSE MONITORING)

7. ABBOTT FREESTYLE LIBRE VS CGM (CONTINUOUS GLUCOSE MONITORING)

8. UNITED KINGDOM – DIABETES POPULATION (2010 – 2024)

8.1 Total Diabetes Population
  8.1.1 Type 1 Diabetes Population
  8.1.2 Type 2 Diabetes Population

9. UNITED KINGDOM - CGM MARKET & FORECAST

9.1 United Kingdom - CGM Market by Components
  9.1.1 Glucose Sensor Market & Forecast
  9.1.2 CGM Transmitter Market & Forecast

10. UNITED KINGDOM – CGM USER (2010 – 2024)

11. CGM REIMBURSEMENT IN UNITED KINGDOM

12. GERMANY – DIABETES POPULATION (2010 – 2024)

12.1 Total Diabetes Population
  12.1.1 Type 1 Diabetes Population
  12.1.2 Type 2 Diabetes Population

13. GERMANY - CGM MARKET & FORECAST

13.1 Germany - CGM Market by Components
  13.1.1 Glucose Sensor Market & Forecast
  13.1.2 CGM Transmitter Market & Forecast

14. GERMANY – CGM USER (2010 – 2024)

15. CGM REIMBURSEMENT IN GERMANY

16. NETHERLANDS – DIABETES POPULATION (2010 – 2024)

16.1 Total Diabetes Population
  16.1.1 Type 1 Diabetes Population
  16.1.2 Type 2 Diabetes Population

17. NETHERLANDS - CGM MARKET & FORECAST

17.1 Netherlands - CGM Market by Components
  17.1.1 Glucose Sensor Market & Forecast
  17.1.2 CGM Transmitter Market & Forecast

18. NETHERLANDS – CGM USER (2010 – 2024)

19. CGM REIMBURSEMENT IN NETHERLANDS

20. SWEDEN – DIABETES POPULATION (2010 – 2024)

20.1 Total Diabetes Population & Forecast
  20.1.1 Type 1 Diabetes Population
  20.1.2 Type 2 Diabetes Population

21. SWEDEN - CGM MARKET & FORECAST

21.1 Sweden – CGM Market by Components
  21.1.1 Glucose Sensor Market & Forecast
  21.1.2 CGM Transmitter Market & Forecast

22. SWEDEN – CGM USER (2010 – 2024)

23. CGM REIMBURSEMENT IN SWEDEN

24. FRANCE – DIABETES POPULATION (2010 – 2024)

24.1 Diabetes Population
  24.1.1 Type 1 Diabetes Population
  24.1.2 Type 2 Diabetes Population

25. FRANCE - CGM MARKET & FORECAST

25.1 France - CGM Market by Components
  25.1.1 Glucose Sensor Market & Forecast
  25.1.2 CGM Transmitter Market & Forecast

26. FRANCE – CGM USER (2010 – 2024)

27. CGM REIMBURSEMENT IN FRANCE

28. SWITZERLAND – DIABETES POPULATION (2010 – 2024)

28.1 Total Diabetes Population
  28.1.1 Type 1 Diabetes Population
  28.1.2 Type 2 Diabetes Population

29. SWITZERLAND - CGM MARKET & FORECAST

29.1 Switzerland - CGM Market by Components
  29.1.1 Glucose Sensor Market & Forecast
  29.1.2 CGM Transmitter Market & Forecast

30. SWITZERLAND – CGM USER (2010 – 2024)

31. CGM REIMBURSEMENT IN SWITZERLAND

32. GROWTH DRIVERS

32.1 Continuous Positive Cost Effective Analysis by Several Countries
32.2 CGM Technology Convenient for both Patients & Physicians

33. CHALLENGES

33.1 Controversy regarding Clinical Benefits

List Of Figures

LIST OF FIGURES

Figure 2-1: Europe – CGM User (Number), 2010 – 2017
Figure 2-2: Europe – Forecast for CGM User (Number), 2018 – 2024
Figure 3-1: Europe – CGM Market (Million US$), 2010 – 2017
Figure 3-2: Europe – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 4-1: Europe – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 4-2: Europe – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 4-3: Europe – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 4-4: Europe – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 5-1: Europe – CGM Market Share by Countries (Percent), 2010 – 2017
Figure 5-2: Europe – Forecast for CGM Market Share by Countries (Percent), 2018 – 2024
Figure 7-1: Abbott Freestyle Libre – User in Europe & Global (Number), May 2017
Figure 8-1: United Kingdom: Diabetes Population (Thousand), 2010 – 2017
Figure 8-2: United Kingdom: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 8-3: United Kingdom: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 8-4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 8-5: United Kingdom: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 8-6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 9-1: United Kingdom – CGM Market (Million US$), 2010 – 2017
Figure 9-2: United Kingdom – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 9-3: United Kingdom – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 9-4: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 9-5: United Kingdom – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 9-6: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 10-1: United Kingdom – CGM User (Number), 2010 – 2017
Figure 10-2: United Kingdom – Forecast for CGM User (Number), 2018 – 2024
Figure 12-1: Germany: Diabetes Population (Thousand), 2010 – 2017
Figure 12-2: Germany: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 12-3: Germany: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 12-4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 12-5: Germany: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 12-6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 13-1: Germany – CGM Market (Million US$), 2010 – 2017
Figure 13-2: Germany – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 13-3: Germany – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 13-4: Germany – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 13-5: Germany – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 13-6: Germany – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 14-1: Germany – CGM User (Number), 2010 – 2017
Figure 14-2: Germany – Forecast for CGM User (Number), 2018 – 2024
Figure 16-1: Netherlands: Diabetes Population (Thousand), 2010 – 2017
Figure 16-2: Netherlands: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 16-3: Netherlands: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 16-4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 16-5: Netherlands: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 16-6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 17-1: Netherlands – CGM Market (Million US$), 2010 – 2017
Figure 17-2: Netherlands – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 17-3: Netherlands – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 17-4: Netherlands – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 17-5: Netherlands – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 17-6: Netherlands – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 18-1: Netherlands – CGM User (Number), 2010 – 2017
Figure 18-2: Netherlands – Forecast for CGM User (Number), 2018 – 2024
Figure 20-1: Sweden: Diabetes Population (Thousand), 2010 – 2017
Figure 20-2: Sweden: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 20-3: Sweden: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 20-4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 20-5: Sweden: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 20-6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 21-1: Sweden – CGM Market (Million US$), 2010 – 2017
Figure 21-2: Sweden – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 21-3: Sweden – Glucose Sensor Market (Million US$), 2010 -2017
Figure 21-4: Sweden – Forecast for Glucose Sensor Market (Million US$), 2018 -2024
Figure 21-5: Sweden – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 21-6: Sweden – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 22-1: Sweden – CGM User (Number), 2010 – 2017
Figure 22-2: Sweden – Forecast for CGM User (Number), 2018 – 2024
Figure 24-1: France – Diabetes Population (Thousand), 2010 – 2017
Figure 24-2: France – Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 24-3: France – Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 24-4: France – Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 24-5: France – Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 24-6: France – Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 25-1: France – CGM Market (Million US$), 2010 – 2017
Figure 25-2: France – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 25-3: France – Glucose Sensor Market (Million), 2010 – 2017
Figure 25-4: France – Forecast for Glucose Sensor Market (Million), 2018 – 2024
Figure 25-5: France – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 25-6: France – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 26-1: France – CGM User (Number), 2010 -2017
Figure 26-2: France – Forecast for CGM User (Number), 2018 -2024
Figure 28-1: Switzerland: Diabetes Population (Thousand), 2010 – 2017
Figure 28-2: Switzerland: Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 28-3: Switzerland: Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 28-4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 28-5: Switzerland: Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 28-6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 29-1: Switzerland – CGM Market (Million US$), 2010 – 2017
Figure 29-2: Switzerland – Forecast for CGM Market (Million US$), 2018 – 2024
Figure 29-3: Switzerland – Glucose Sensor Market (Million US$), 2010 – 2017
Figure 29-4: Switzerland – Forecast for Glucose Sensor Market (Million US$), 2018 – 2024
Figure 29-5: Switzerland – CGM Transmitter Market (Million US$), 2010 – 2017
Figure 29-6: Switzerland – Forecast for CGM Transmitter Market (Million US$), 2018 – 2024
Figure 30-1: Switzerland – CGM User (Number), 2010 – 2017
Figure 30-2: Switzerland – Forecast for CGM User (Number), 2018 – 2024

List Of Tables

LIST OF TABLES

Table 6 1: Current Status of Global Real-Time Continuous Glucose Monitoring Coverage and Reimbursement, 2017
Table 7 1: Abbott Freestyle Libre vs. CGM